Characterization of Collaborative Cross mouse founder strain CAST/EiJ as a novel model for lethal COVID-19

Mutations in SARS-CoV-2 variants of concern (VOCs) have expanded the viral host range beyond primates, and a few other mammals, to mice, affording the opportunity to exploit genetically diverse mouse panels to model the broad spectrum of responses to infection in patient populations. Here we surveyed responses to VOC infection in genetically diverse Collaborative Cross (CC) founder strains. Infection of wild-derived CC founder strains produced a broad range of viral burden, disease susceptibility and survival, whereas most other strains were resistant to disease despite measurable lung viral titers. In particular, CAST/EiJ, a wild-derived strain, developed high lung viral burdens, more severe lung pathology than seen in other CC strains, and a dysregulated cytokine profile resulting in morbidity and mortality. These inbred mouse strains may serve as a valuable platform to evaluate therapeutic countermeasures against severe COVID-19 and other coronavirus pandemics in the future.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2024-10-24
DOI
https://doi.org/10.1038/s41598-024-77087-1
Citations
3
Primary Topic
Bacteriophages and microbial interactions
Type
article
Field-Weighted Citation Impact
1.38

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characterization of Collaborative Cross mouse founder strain CAST/EiJ as a novel model for lethal COVID-19

Tricia Hart, William W. Reiley, Mike Tighe, Frank M. Szaba et al.
3 citations
Scientific Reports
Bacteriophages and microbial interactions
1.38
article

Characterization of Collaborative Cross mouse founder strain CAST/EiJ as a novel model for lethal COVID-19

Tricia Hart, William W. Reiley, Mike Tighe, Frank M. Szaba, Larry Kummer, Sean Casey, Mark D. Adams, Cathleen M. Lutz, Nadia Rosenthal, Kathleen G. Lanzer, Kelsey L. Travis, Isaac Lowthian Bell, Tres Cookenham, Naga Rama Kothapalli, Candice N. Baker, Jerrold M. Ward, Olivia Bedard, Purva Vats, Shelton S. Bradrick, Priya Shanbhag, Natalie Oberding, Janine Hvizdos, Jeffrey M. Harder, Debra K. Duso
article en
3 citations

Abstract

Mutations in SARS-CoV-2 variants of concern (VOCs) have expanded the viral host range beyond primates, and a few other mammals, to mice, affording the opportunity to exploit genetically diverse mouse panels to model the broad spectrum of responses to infection in patient populations. Here we surveyed responses to VOC infection in genetically diverse Collaborative Cross (CC) founder strains. Infection of wild-derived CC founder strains produced a broad range of viral burden, disease susceptibility and survival, whereas most other strains were resistant to disease despite measurable lung viral titers. In particular, CAST/EiJ, a wild-derived strain, developed high lung viral burdens, more severe lung pathology than seen in other CC strains, and a dysregulated cytokine profile resulting in morbidity and mortality. These inbred mouse strains may serve as a valuable platform to evaluate therapeutic countermeasures against severe COVID-19 and other coronavirus pandemics in the future.

Scientific ReportsVol. 14(1)
Trudeau Institute (US), Lung Institute (US), Jackson Laboratory (US), Imperial College London (GB)
F. M. Kirby Foundation, James N. Kirby Foundation, National Institutes of Health, National Institute of Allergy and Infectious Diseases
Openalex Percentile: Top 18%
Bacteriophages and microbial interactions
1.38
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.